Alcohol use accelerates HIV disease progression

AIDS Research and Human Retroviruses

Volumn 26, Issue 5, 2010, Pages 511-518

  Baum, Marianna K ^a   Rafie, Carlin ^a   Lai, Shenghan ^b   Sales, Sabrina ^a   Page, John Bryan ^c   Campa, Adriana ^a  

^a FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; COCAINE; ILLICIT DRUG;

ADULT; AGE; ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ARTICLE; CD4 LYMPHOCYTE COUNT; DISEASE COURSE; FEMALE; GENDER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SUBSTANCE ABUSE; VIRUS LOAD;

ADULT; ALCOHOL DRINKING; ALCOHOLISM; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; DISEASE PROGRESSION; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; LONGITUDINAL STUDIES; MALE; MEDICATION ADHERENCE; MIDDLE AGED; QUESTIONNAIRES; SUBSTANCE-RELATED DISORDERS; VIRAL LOAD;

EID: 77952561522     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2009.0211     Document Type: Article

References (45)

1. WHO Global Status Report on Alcohol. 2004. Accessed July 30, 2009 http://www.who.int/substance-abuse/publications/ globalstatusreportalcohol2004- alcconsumpt.pdf.
2. http://www.cdc.gov/alcohol/index.htm. Reviewed April, 2008, accessed April 30, 2009.
3. Phillips SJ, Freedberg KA, Traphagen ET, Horton NJ, and Samet JH: Screening for alcohol problems in HIV-infected primary care patients (abstract). J Gen Intern Med 2001;16: 165.
4. Samet JH, Phillips SJ, Horton NJ, Traphagen ET, and Freedberg KA: Detecting alcohol problems in HIV-infected patients: Use of the CAGE questionnaire. AIDS Res Hum Retroviruses 2004;20:151-155.
5. Congliaro J, Gordon AJ, McGinnis KA, Tabeneck L, and Justice AC: How harmful is hazardous alcohol use and abuse in HIV infection: Do healthcare providers know who is at risk? J Acquir Immune Defic Syndr 2003;33:521-525.
6. Kapasi AA, Geeta P, Goenka A, et al.: Ethanol promotes T cell apoptosis through the mitochondrial pathway. Immunology 2003;108:313-320.
7. Barve SS, Kelkar SV, Gobejishvilli L, Joshi-Barve S, and McClain CJ: Mechanisms of alcohol-mediated CD4+ T lymphocyte death: Relevance to HIV and HCV pathogenesis. Front Biosci 2002;7:1689-1696.
8. Balkan J, Vural P, Oztezcan S, et al.: Increased LDL+VLDL oxidizability and plasma homocysteine levels in chronic alcoholic patients. J Nutr Sci Vitaminol (Tokyo) 2005;51(2): 99-103.
9. Yuksel N, Uzbay IT, Karakilic H, Aki OE, Etik C, and Erbas D: Increased serum nitrite/nitrate (NOx) and malondialdehyde (MDA) levels during alcohol withdrawal in alcoholic patients. Pharmacopsychiatry 2005;38(2):95-96.
10. Kopczynska E, Lampka M, Torlinski L, and Ziolkowski M: The level of 8-iso-prostaglandin F2 alpha, 4-hydroxynonenal and malondialdehyde in alcohol dependent men during combined therapy. Psychiatr Pol 2002;36(2):293-302.
11. Fromenty B, Grimbert S, Mansouri A, et al.: Hepatic mitochondrial DNA deletion in alcoholics. Association with microvesicular steatatosis. Gastroenterology 1995;108:193-200.
12. Mansouri A, Fromenty B, Berson A, et al.: Multiple hepatic mitochondrial DNA deletions suggest premature oxidative aging in alcoholic patients. J Hepatol 1997;27:96-102.
13. Mansouri A, Gaou I, De Kerguenec C, et al.: An alcoholic binge causes massive degradation of hepatic mitochondrial DNA in mice. Gastroenterology 1999;117:181-190.
14. Cahill A, Cunningham CC, Adachi M, et al.: Effects of alcohol and oxidative stress on liver pathology: The role of the mitochondrion. Alcohol Clin Exp Res 2002;26(6):907-915.
15. Watson RR, Borgs P, Witte M, et al.: Alcohol, immunomodulation, and disease. Alcohol Alcohol 1994;29(2):131-139.
16. Kaslow RA, Blackwelder WC, Ostrow DG, et al.: No evidence for a role of alcohol or other psychoactive drugs in accelerating immunodeficiency in HIV-1 positive individuals. JAMA 1989;261:3424-3429.
17. Coates RA, Farewell VT, Raboud J, et al.: Cofactors of progression to acquired immunodeficiency syndrome in a cohort of male sexual contacts of men with human immunodeficiency virus disease. Am J Epidemiol 1990;132(4):717-722.
18. Veugelers PJ, Page KA, Tindall B, et al.: Determinants of HIV progression among homosexual men registered in the Tricontinental Seroconverter Study. Am J Epidemiol 1994; 140(8):747-758.
19. Penkower L, Dew MA, Kingsley L, et al.: Alcohol consumption as a cofactor in the progression of HIV infection and AIDS. Alcohol Alcohol 1995;12(6):547-552.
20. Wang JY, Liang B, and Watson RR: Alcohol consumption alters cytokine release during murine AIDS. Alcohol Alcohol 1997;14(2):155-159.
21. Bautista A: Chronic alcohol intoxication attenuates human immunodeficiency virus-1 glycoprotein 120-induced superoxide anion release by isolated Kupffer cells. Alcohol Clin Exp Res 1998;22(2):474-480.
22. Watson RR, Odeley OE, Darban HR, and Lopez MC: Modification of lymphoid subsets by chronic ethanol consumption in C57BL/6 mice infected with LP-BM4 murine leukemia virus. Alcohol Alcohol 1992;27(4):417-424.
23. Bermudez LE, Petrofsky M, Kolonoski P, and Young LS: An animal model of Mycobacterium avium complex disseminated infection after colonization of intestinal tract. J Infect Dis 1992;165:75-79.
24. Darban H, Watson RR, Darban JR, and Shahbazian LM: Modification of resistance to Streptococcus pneumonia by dietary ethanol, immunization, and murine retroviral infection. Alcohol Clin Exp Res 1992;16(5):846-851.
25. Bagasra O, Kajdacsy-Balla A, and Lischner HW: Effects of alcohol ingestion on in vitro susceptibility of peripheral blood mononuclear cells to infection with HIV and of selected T-cell functions. Alcohol Clin Exp Res 1989;13(5):636-643.
26. Bagasra O, Kajdacsy-Balla A, Lischner HW, and Pomerantz RJ: Alcohol intake increases human immunodeficiency virus type 1 replication in human peripheral blood mononuclear cells. J Infect Dis 1993;167:789-797. (Pubitemid 23088246)
27. Molina PE, McNurlan M, Tathmacher J, et al.: Chronic alcohol accentuates nutritional, metabolic, and immune alterations during asymptomatic simian immunodeficiency virus infection. Alcohol Clin Exp Res 2006;30(12):2065-2078.
28. Bagby GJ, Zhang P, Purcell JE, Didier PJ, and Nelson S: Chronic binge ethanol consumption accelerates progression of simian immunodeficiency virus disease. Alcohol Clin Exp Res 2006;30(10):1781-1790.
29. Molina PE, Lang CH, McNurian M, Bagby GJ, and Nelson S: Chronic alcohol accentuates simian acquired immunodeficiency syndrome-associated wasting. Alcohol Clin Exp Res 2008;32(1):138-147.
30. Howard AA, Arnsten JH, Lo Y, et al.: A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women. AIDS 2002;16(16):2175-2182.
31. Samet JH, Horton NJ, Meli S, Freedberg KA, and Palepu A: Alcohol consumption and antiretroviral adherence among HIV-infected persons with alcohol problems. Alcohol Clin Exp Res 2004;28(4):572-577.
32. Miguez MJ, Shor-Posner G, Morales G, Rodriguez A, and Burbano X: HIV treatment in drug abusers: Impact of alcohol use. Addict Biol 2003;8:33-37.
33. Fabris P, Tostitti G, Manfrin V, et al.: Does alcohol intake affect highly active antiretroviral therapy (HAART) response in HIV-positive patients? J Acquir Immune Defic Syndr 2000;25(1):92-93.
34. Palepu A, Horton NJ, Tibbetts N, Meli S, and Samet JH: Uptake and adherence to highly active antiretroviral therapy among HIV-infected people with alcohol and other substance use problems: The impact of substance abuse treatment. Addiction 2004;99:361-368.
35. Samet JH, Cheng DM, Libman H, Nunes DP, Alperen JK, and Saitz R: Alcohol consumption and HIV disease progression. J Acquir Immune Defic Syndr 2007;46(2):194-199.
36. Kapasi AA, Geeta P, Goenka A, et al.: Ethanol promotes T cell apoptosis through the mitochondrial pathway. Immunology 2003;108:313-320.
37. Barve SS, Kelkar SV, Gobejishvilli L, Joshi-Barve S, and McClain CJ. Mechanisms of alcohol-mediated CD4+ T lymphocyte death: relevance to HIV and HCV pathogenesis. Front Biosci 2002;7:1689-1696.
38. Baum MK, Rafie C, Lai S, Sales S, Page B, and Campa A. Crack-cocaine use accelerates HIV disease progression in a cohort of HIV-positive drug users. J Acquir Immune Defic Syndr 2008;50:93-99.
39. Webber MP, Schonenbaum EE, Gourevitch MN, Buono D, and Klein RS. A prospective study of HIV disease progression in female and male drug users. AIDS 1999;13(2):257-262.
40. Siddiqui NS, Brown LS Jr, and Makuch RW: Short-term declines in CD4 levels associated with cocaine use in HIV-1 seropositive, minority injecting drug users. J Natl Med Assoc 1993;85:293-296.
41. Lucas GM, Gebo KA, Chaisson RE, and Moore RD: Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic. AIDS 2002;16:767-774.
42. Arnsten JH, Demas PA, Grant RW, et al.: Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. J Gen Intern Med 2002;17:377-381.
43. Hinkin CH, Barclay TR, Castellon SA, et al.: Drug use and medication adherence among HIV-1 infected individuals. AIDS Behave 2007;11:185-194.
44. Campa A, Jayaweera DT, Rafie C, Sales S, Page JB, and Baum MK: When access to antiretroviral for all is not enough. J Public Admin Manage 2007;12(3):147-149.
45. Lucas GM, Griswold M, Gebo KA, Keruly J, Chaisson RE, and Moore RD: Illicit drug use and HIV-1 disease progression: A longitudinal study in the era of highly active antiretroviral therapy. Am J Epidemiol 2006;163:412-420.